ClinicalTrials.Veeva

Menu

Skeletal Muscle Parameters of Liver Cirrhosis in Non-invasive Imaging and Outcome (SLIM)

U

University Hospital Bonn (UKB)

Status

Enrolling

Conditions

Liver Cirrhosis

Treatments

Diagnostic Test: imaging

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The principal aim of this study is to analyse L3-SMI (skeletal muscle index) in a cohort of patients with decompensated liver cirrhosis and TIPS (transjugular intrahepatic portosystemic shunt), and compare the prognostic power with TPMT (transverse psoas muscle thickness). Furthermore, the role of myosteatosis, determined in CT by L3-SMI, MRI and ultrasound will be studied.

Full description

The principal aim of this study is to analyse L3-SMI (skeletal muscle index) in a cohort of patients with decompensated liver cirrhosis and TIPS (transjugular intrahepatic portosystemic shunt), and compare the prognostic power with TPMT (transverse psoas muscle thickness). Furthermore, the role of myosteatosis, determined in CT by L3-SMI, MRI and ultrasound will be studied.

Enrollment

400 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • liver cirrhosis of any etiology
  • CT scan available

Exclusion criteria

  • HCC or any malignant disease

Trial contacts and locations

3

Loading...

Central trial contact

Michael Praktiknjo, MD; Johannes Chang, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems